Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript

Mar 28, 2023 / 05:00PM GMT
Paul Matteis - Stifel Financial Corp. - Analyst

Great. Good afternoon, everybody. It's my pleasure to be with Ian Mortimer, President and CEO of Xenon. Ian, it's always great to see you. We've done a number of panels together even in the past six months, so sorry to have to deal with me again. And Sherry Aulin, CFO. Sorry, Sherry, you disappeared for a second off of my screen, so I didn't know if [you're in this meeting] or not.

Before we start, Ian, did you run this morning? And if so, how far?

Ian Mortimer - Xenon Pharmaceuticals, Inc. - President and CEO

I did run this morning. I did 10 miles, yeah.

Paul Matteis - Stifel Financial Corp. - Analyst

Okay. Easy day?

Ian Mortimer - Xenon Pharmaceuticals, Inc. - President and CEO

Easy day.

Questions and Answers:

Paul Matteis - Stifel Financial Corp. - Analyst

All right. That's awesome. Cool, okay. With that, do you want to just give us an update of the 1101 pivotal
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot